March 6, 2026 · Form 4 insider transaction
Dier Mardi sold 160 shares of Madrigal Pharmaceuticals, Inc. at $429.00 per share, a transaction worth $68.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 2, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $428.51 to $429.24, inclusive.